Q1 2026 DiaSorin SpA Earnings Call Transcript
Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the DiaSorin First Quarter 2026 Results Conference Call. (Operator Instructions) At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin.
Please go ahead, sir.
Thank you, operator. Ladies and gentlemen, good afternoon, and welcome to the Q1 conference call. As usual, I will give some color to the financial results. And then I will let our CFO, Alberto Donati, to take you through the numbers. I'm going to make my comments at constant exchange rate.
In quarter one, 2026, as anticipated during our full year results call. Quarter registered a slightly negative performance, minus 3% and mainly as a result of the following factors. First one, as reported by all our competitors, the softness of the flu season with declining volume by roughly 25%. And this clearly has affected the performance of our molecular diagnostic platforms since
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

